Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Shaima Shawagfeh"'
Autor:
Ibrahim Al-Faouri, Rana Abu Farha, Daher Al-rabadi, Nasr Alrabadi, Sawsan Abuhammad, Suzan AlRabadi, Razan Haddad, Tareq L. Mukattash, Shaima Shawagfeh
Publikováno v:
Journal of Pharmaceutical Health Services Research. 12:78-86
ObjectivesHealth departments endeavor to give care to individuals to remain in healthy conditions. Medications errors (MEs), one of the most types of medical errors, could be venomous in clinical settings. Patients will be harmed physically and psych
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9d840c19c60be0266d464fb55b6e4803
https://doi.org/10.1093/jphsr/rmaa025
https://doi.org/10.1093/jphsr/rmaa025
Publikováno v:
Annals of Clinical Oncology. :1-6
Having cancer impacts the patient both psychologically and physically. However, if cancer is accompanied with HFS, the patient’s condition gets even worse. Capecitabine is a prodrug approved to treat several types of cancer such as breast and color
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::655f8049a1f070621a07edf777de159a
https://doi.org/10.31487/j.aco.2020.02.03
https://doi.org/10.31487/j.aco.2020.02.03
Autor:
Razan Haddad, Nasr Alrabadi, Rabia Haddad, Shaima Shawagfeh, Daher Al-rabadi, Sawsan Abuhammad, Tareq Mukatash
Publikováno v:
Journal of Pharmaceutical Health Services Research. 11:237-243
ObjectivesMedication error (ME) is like a venom dispersing in clinical practice, particularly the process of drugs’ administration. Nurses, as the direct drug administrators, are in critical defense lines to prevent its occurrence. Therefore, our a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::604a02d80efb739ae1c19c9b849428d7
https://doi.org/10.1111/jphs.12348
https://doi.org/10.1111/jphs.12348
Publikováno v:
Oncology Research and Treatment. 43:694-702
Background: Capecitabine is frequently used alone or combined with other chemotherapy agents for the treatment of metastatic breast cancer in relapsed patients. Objective: The objective of this meta-analysis is to evaluate the effectiveness and safet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bc02eebfbdbd8e8c0cd7cad227c4f1b1
https://doi.org/10.1159/000510356
https://doi.org/10.1159/000510356